Global action on antimicrobial resistance: lessons from the history of climate change and tobacco control policy.
作者信息
Pitchforth Emma, Smith Elta, Taylor Jirka, Davies Sally, Ali Gemma-Claire, d'Angelo Camilla
机构信息
College of Medicine and Health, University of Exeter, Exeter, UK
Independent Researcher, London, UK.
出版信息
BMJ Glob Health. 2022 Jul;7(7). doi: 10.1136/bmjgh-2022-009283.
Abstract
摘要
相似文献
1
Global action on antimicrobial resistance: lessons from the history of climate change and tobacco control policy.全球抗微生物药物耐药性行动：气候变化和烟草控制政策历史的教训
BMJ Glob Health. 2022 Jul;7(7). doi: 10.1136/bmjgh-2022-009283.
2
Governing Global Antimicrobial Resistance: 6 Key Lessons From the Paris Climate Agreement.治理全球抗微生物药物耐药性：从《巴黎气候协定》中汲取的6个关键教训。
Am J Public Health. 2022 Apr;112(4):553-557. doi: 10.2105/AJPH.2021.306695.
3
What and how can we learn from complex global problems for antimicrobial resistance policy? A comparative study combining historical and foresight approaches.从复杂的全球问题（如抗菌素耐药性）中，我们能学到什么，又该如何为抗菌素耐药性政策提供借鉴？一项结合历史和前瞻性方法的比较研究。
J Glob Antimicrob Resist. 2023 Dec;35:110-121. doi: 10.1016/j.jgar.2023.08.019. Epub 2023 Sep 14.
4
Tackling antimicrobial resistance at global and local scales.全球和地方层面的抗微生物药物耐药性应对措施
Trends Microbiol. 2015 Sep;23(9):524-6. doi: 10.1016/j.tim.2015.06.005.
5
Climate policy: lessons from tobacco control.气候政策：烟草控制的经验教训。
Lancet. 2009 Dec 12;374(9706):1955-6. doi: 10.1016/S0140-6736(09)61959-0.
6
Tackling antimicrobial resistance and climate change.应对抗微生物药物耐药性与气候变化。
Lancet. 2018 Dec 8;392(10163):2435-2436. doi: 10.1016/S0140-6736(18)32413-9.
7
The twin challenges of longevity and climate change in controlling antimicrobial resistance.控制抗菌药物耐药性面临的长寿和气候变化双重挑战。
J Antibiot (Tokyo). 2024 Jul;77(7):399-402. doi: 10.1038/s41429-024-00730-6. Epub 2024 May 9.
8
Antimicrobial resistance-what can we learn from climate change?抗菌药物耐药性——我们能从气候变化中学到什么？
Lancet Respir Med. 2016 Nov;4(11):845. doi: 10.1016/S2213-2600(16)30332-0.
9
Bridging the commitment-compliance gap in global health politics: Lessons from international relations for the global action plan on antimicrobial resistance.弥合全球卫生政治中的承诺-合规差距：国际关系对抗菌药物耐药性全球行动计划的启示。
Glob Public Health. 2021 Jan;16(1):60-74. doi: 10.1080/17441692.2020.1788623. Epub 2020 Jul 4.
10
Antimicrobial resistance and antimicrobial use animal monitoring policies in Europe: Where are we ?欧洲的抗菌药物耐药性和抗菌药物使用动物监测政策：我们处于什么位置？
J Public Health Policy. 2017 May;38(2):185-202. doi: 10.1057/s41271-017-0067-y.
引用本文的文献
1
Systems Policy Analysis for Antimicrobial Resistance Targeted Action (SPAARTA): A Research Protocol.抗菌药物耐药性靶向行动的系统政策分析（SPAARTA）：一项研究方案。
Wellcome Open Res. 2025 Jul 30;9:700. doi: 10.12688/wellcomeopenres.22923.2. eCollection 2024.
2
Invisible Engines of Resistance: How Global Inequities Drive Antimicrobial Failure.隐形的耐药引擎：全球不平等如何导致抗菌药物失效
Antibiotics (Basel). 2025 Jun 30;14(7):659. doi: 10.3390/antibiotics14070659.
3
Regulating antimicrobial resistance in the environment: analysis of Thailand legal framework and areas for reinforcement.环境中抗菌药物耐药性的监管：泰国法律框架分析及强化领域
Sci One Health. 2025 Apr 30;4:100110. doi: 10.1016/j.soh.2025.100110. eCollection 2025.
4
Progress in visible-light-activated photocatalytic coatings to combat implant-related infections: From mechanistic to translational roadmap.用于对抗植入物相关感染的可见光激活光催化涂层的进展：从作用机制到转化路线图。
Bioact Mater. 2025 May 11;51:83-137. doi: 10.1016/j.bioactmat.2025.04.037. eCollection 2025 Sep.
5
The Role and Mechanisms of Antimicrobial Peptides in Overcoming Multidrug-Resistant Bacteria.抗菌肽在克服多重耐药细菌中的作用及机制
Molecules. 2024 Dec 31;30(1):128. doi: 10.3390/molecules30010128.
6
Prevalence and Antibiotic Susceptibility of Pathogenic Enterobacteria Strains from Three Biotopes in the City of Ouagadougou (Burkina Faso).布基纳法索瓦加杜古市三个生物群落中致病性肠杆菌菌株的流行情况及抗生素敏感性
Infect Drug Resist. 2024 Dec 30;17:5909-5924. doi: 10.2147/IDR.S485200. eCollection 2024.
7
Probing the past: historical case study analysis to inform more just and sustainable global health partnerships in education.探究过去：历史案例研究分析，为更公正和可持续的教育全球健康伙伴关系提供信息。
BMJ Glob Health. 2024 Nov 18;9(11):e015415. doi: 10.1136/bmjgh-2024-015415.
8
Opportunities and challenges in antimicrobial resistance policy including animal production systems and humans across stakeholders in Argentina: a context and qualitative analysis.阿根廷各利益相关者在包括动物生产系统和人类在内的抗菌药物耐药性政策方面的机遇与挑战：背景与定性分析。
BMJ Open. 2024 Jun 17;14(6):e082156. doi: 10.1136/bmjopen-2023-082156.
9
How Antimicrobial Resistance Is Linked to Climate Change: An Overview of Two Intertwined Global Challenges.抗菌药物耐药性与气候变化的关联：两个相互交织的全球性挑战概述。
Int J Environ Res Public Health. 2023 Jan 17;20(3):1681. doi: 10.3390/ijerph20031681.
本文引用的文献
1
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.2019 年全球细菌对抗菌药物耐药性的负担：系统分析。
Lancet. 2022 Feb 12;399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19.
2
The interrelationships between antimicrobial resistance, COVID-19, past, and future pandemics.抗微生物药物耐药性、COVID-19 与过去和未来大流行之间的相互关系。
J Infect Public Health. 2021 Jan;14(1):53-60. doi: 10.1016/j.jiph.2020.10.018. Epub 2020 Dec 9.
3
The origin, supply chain, and deforestation risk of Brazil's beef exports.巴西牛肉出口的起源、供应链和森林砍伐风险。
Proc Natl Acad Sci U S A. 2020 Dec 15;117(50):31770-31779. doi: 10.1073/pnas.2003270117. Epub 2020 Dec 1.
4
Exploring Models for an International Legal Agreement on the Global Antimicrobial Commons: Lessons from Climate Agreements.探索关于全球抗菌共用物的国际法律协议模式：气候协议的经验教训。
Health Care Anal. 2023 Mar;31(1):25-46. doi: 10.1007/s10728-019-00389-3.
5
Social norms as solutions.作为解决方案的社会规范。
Science. 2016 Oct 7;354(6308):42-43. doi: 10.1126/science.aaf8317.
6
Achieving global targets for antimicrobial resistance.实现抗菌药物耐药性的全球目标。
Science. 2016 Aug 26;353(6302):874-5. doi: 10.1126/science.aaf9286. Epub 2016 Aug 18.
7
Policy: An intergovernmental panel on antimicrobial resistance.政策：一个关于抗微生物药物耐药性的政府间小组。
Nature. 2014 May 29;509(7502):555-7. doi: 10.1038/509555a.
8
The first Surgeon General's report on smoking and health: the 50th anniversary.第一份卫生局局长关于吸烟与健康的报告：五十周年纪念
CA Cancer J Clin. 2014 Jan-Feb;64(1):5-8. doi: 10.3322/caac.21210. Epub 2013 Nov 18.
Zotero 插件